Showing results (251-260 of 346) with videos related to
Sort By:
Pageof 35
Cancer Research|April 1, 1992
Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomasC T Fong, P S White, K Peterson, et al.Cancer Research|August 26, 2020
Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid TumorsFerro Nguyen, Peng Guan, David T Guerrero, et al.Progress in Clinical and Biological Research|January 1, 1994
Preferential amplification of the paternal allele in neuroblastomas with N-myc amplificationJ M Cheng, J L Hiemstra, S S Schneider, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastomaM A Grotzer, M D Hogarty, A J Janss, et al.Journal of Science and Medicine in Sport|April 13, 2021
Short term heat acclimation reduces heat strain during a first, but not second, consecutive exercise-heat exposureRiana R Pryor, J Luke Pryor, Lesley W Vandermark, et al.Oncogene|January 8, 2005
Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomasJohannes H Schulte, Alexander Schramm, Ludger Klein-Hitpass, et al.Physical Review Letters|September 4, 2008
Direct mass measurement of the four-neutron halo nuclide 8HeV L Ryjkov, M Brodeur, T Brunner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group studyM L Schmidt, J N Lukens, R C Seeger, et al.Biomaterials|March 16, 2015
Nanoparticle-mediated delivery of a rapidly activatable prodrug of SN-38 for neuroblastoma therapyIvan S Alferiev, Radhika Iyer, Jamie L Croucher, et al.Proceedings of the National Academy of Sciences of the United States of America|September 14, 2000
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastomaX X Tang, H Zhao, M E Robinson, et al.Pageof 35